<DOC>
	<DOCNO>NCT00075348</DOCNO>
	<brief_summary>RATIONALE : The identification gene mutation individual risk von Hippel-Lindau syndrome may allow doctor good determine genetic process involve development cancer . PURPOSE : This genetic study find gene mutation participant von Hippel-Lindau syndrome risk develop von Hippel-Lindau syndrome .</brief_summary>
	<brief_title>Genetic Study Identify Gene Mutations Participants Previously Enrolled Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome Are Risk Von Hippel-Lindau Syndrome</brief_title>
	<detailed_description>OBJECTIVES : - Obtain laboratory identification confirmation research result gene mutation participant previously enrol NCI-99-C-0053 von Hippel-Lindau ( VHL ) syndrome risk VHL syndrome . - Determine genotype status participant . OUTLINE : Participants submit blood buccal sample genetic mutation analysis . Participants may receive genetic counseling and/or result genetic testing , desire . PROJECTED ACCRUAL : A maximum 260 participant accrue study .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Von Hippel-Lindau Disease</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Prior enrollment von HippelLindau ( VHL ) Syndrome Epidemiology Study NCI99C0053 Meets 1 follow criterion : Diagnosis VHL syndrome At risk VHL syndrome Family member patient VHL syndrome VHL syndrome genotype know PATIENT CHARACTERISTICS : Age Adult Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>renal cell carcinoma</keyword>
	<keyword>von Hippel-Lindau syndrome</keyword>
</DOC>